Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Nowitzki-Grimm, P. Grimm, H. Thöni, H. Classen (1991)
Diagnosis of magnesium statusMagnesium-bulletin, 13
S. Hall, C. Fry (1992)
Magnesium affects excitation, conduction, and contraction of isolated mammalian cardiac muscle.The American journal of physiology, 263 2 Pt 2
(1979)
Gastrointestinal magnesium absorption
W. Douglas, R. Rubin (1963)
The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus—secretion couplingThe Journal of Physiology, 167
D. Antoni, M. Engel, N. Gumpel (1989)
Die Therapie von supraventrikulären und ventrikulären Herzrhythmusstörungen mit MagnesiumMagnesium-bulletin, 11
A. Szyszka (1984)
[Magnesium and the heart].Kardiologia polska, 27 10
(1981)
Klinische Studien zur Mg-Behandlung des tetanischen Syndroms
(1979)
Tagesrhythmische Schwankungen der Magnesiumkonzentration in Plasma und Erythrozyten
U. Karbach, H. Feldmeier (1991)
New clinical and experimental aspects of intestinal magnesium transport.Magnesium research, 4 1
(1991)
Hochdosierte orale MagnesiumTherapie bei Koronarer Herzerkrankung
B. Altura, C. Wilimzig, T. Trnovec, Š. Nyulassy, B. Altura (1994)
Comparative effects of a Mg-enriched diet and different orally administered magnesium oxide preparations on ionized Mg, Mg metabolism and electrolytes in serum of human volunteers.Journal of the American College of Nutrition, 13 5
(1991)
Biofiquivalenz-Qualitfitsbewertung wirkstoffgleicher Fertigarzneimittel, part 1/I
Jill Lindberg, Margaret Zobitz, J. Poindexter, Charles Pak (1990)
Magnesium bioavailability from magnesium citrate and magnesium oxide.Journal of the American College of Nutrition, 9 1
M. Nicar, C. Pak (1982)
Oral magnesium load test for the assessment of intestinal magnesium absorption. Application in control subjects, absorptive hypercalciuria, primary hyperparathyroidism, and hypoparathyroidism.Mineral and electrolyte metabolism, 8 1
B. Mühlbauer, M. Schwenk, W. Coram, K. Antonin, P. Étienne, P. Bieck, F. Douglas (2004)
Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteersEuropean Journal of Clinical Pharmacology, 40
(1992)
Dobowe zmiany stcezenia magnezu w surowicy zdrowych ludzi
H. Ebel, T. Günther (1980)
Magnesium Metabolism: A Review, 18
E. Graf (1990)
Bioäquivalenz; Qualitätsbewertung wirkstoffgleicher Fertigarzneimittel. Hsg. von H. Blume und E. Mutschler unter Mitarb. von G. Wendt, G. Stenzhorn, M. Siewert und M. Schäfer‐Korting. 1. Erg.‐Lfg. 1990, Govi‐Verlag, Eschborn. Mit Ordner DM 118,–Pharmazie in Unserer Zeit, 19
(1990)
Zur Verwertbarkeit von Magnesium aus verschiedenen Darreichungsformen
R. Collins, R. Peto, M. Flather, S. Parish, P. Sleight, M. Conway, A. Pipilis, C. Baigent, D. Barnett, J. Boissel, A. Budaj, J. Cairns, L. Ceremużyński, Af Cohen, G. Backer, R. Díaz, F. Dienstl, P. Dove, M. Franzosi, M. Genoni, D. Halon, J. Heikkila, C. Hennekens, J. Horgan, D. Hunt, R. Kala, N. Karatzas, A. Keech, M. Keltai, J. Kjekshus, M. Kornitzer, R. Koster, P. Landless, P. Lechleitner, A. Leizorovicz, B. Lewis, L. Lundkvist, S. MacMahon, A. Maggioni, R. Malacrida, T. Meyer, T. Moccetti, D. Ocallaghan, E. Paolasso, L. Piegas, A. Reikvam, P. Ridker, T. Ryan, R. Schroder, R. Seabragomes, Jemr Sousa, G. Tognoni, A. Turpie, Valentin, J. Varigos, H. White, L. Wilhelmsen, K. Woods, S. Yusuf, A. Piombo, La Guzman, Dc Montenegro, G. Irusta, Raymond Schneider, C. Cuneo, B. Chamorro, Gerardo Espinosa, M. Moreno, Mm Rios, R. Doll, K. Fox, D. Julian, P. Meier, E. Sandoya, J. Perez (1995)
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 345
L. Iseri, J. Freed, A. Bures (1975)
Magnesium deficiency and cardiac disorders.The American journal of medicine, 58 6
M. Ghani, M. Rabah (1977)
Effect of magnesium chloride on electrical stability of the heart.American heart journal, 94 5
K. Woods, S. Fletcher, C. Roffe, Y. Haider (1992)
Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)The Lancet, 339
H. Schlebusch, K. Pietrzik, G. Gilles-Schmogner, A. Zien (1992)
BIOVERFUGBARKEIT VON MAGNESIUM ALS MAGNESIUMOROTAT UND MAGNESIUMHYDROXIDKARBONATMedizinische Welt, 43
L. Spatling (1985)
Magnesiummangel und vorzeitige WehentätigkeitMagnesium-bulletin, 7
(1975)
Zur Pharmakologie und Pharmakokinetik von Magnesium
P. Lücker, T. Nestler (1985)
Zur therapeutischen Verwertbarkeit von MagnesiumzubereitungenMagnesium-bulletin, 7
Albert Dichtl, Wolfgang Vierling (1991)
Inhibition by magnesium of calcium inward current in heart ventricular muscle.European journal of pharmacology, 204 3
228 49 49 4 4 C. Wilimzig R. Latz W. Vierling E. Mutschler T. Trnovec S. Nyulassy Datapharm GmbH, Planegg Munich Germany Pharmacological Institute Technical University of Munich Biedersteiner Strasse 29 D-80802 Munich Germany Pharmacological Institute University of Frankfurt, Biocenter Niederusel Frankfurt am Main Germany Institute for Preventive and Clinical Medicine University of Bratislava Slovak Republic Abstract Magnesium plasma concentrations were measured in healthy probands before and after administration of trimagnesium dicitrate by the oral and intravenous routes. There was a notable circadian fluctuation of the plasma concentration with a peak in the evening hours. After oral administration of 12 and 24 mmol magnesium, a long-lasting, statistically significant increase in plasma magnesium concentration measured as the increase in area under the curve (AUC) between 0 and 12 h, of 3.1% and 4.6%, respectively, was found. After intravenous administration of 4 and 8 mmol magnesium, AUCs increased by 9.5% and 16.1%, respectively. The decline in the plasma magnesium concentration after i.v. administration was compatible with a three-compartment model with a terminal half-time of about 8 h. Although no absolute value of the oral bioavailability of trimagnesium dicitrate could be determined from the data, our results may be important in helping to elucidate the influence of magnesium preparations on the plasma magnesium concentration. By comparing the effects of different preparations, it should be possible to estimate the relative oral bioavailability and the bioequivalence of these preparations.
European Journal of Clinical Pharmacology – Springer Journals
Published: Jan 1, 1996
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.